On the occasion of World Alzheimer's Day, Yatharth Hospital, Sector 20, Faridabad, has launched the region’s first dedicated Memory Clinic aimed at providing comprehensive assessment, diagnosis and management for individuals experiencing memory loss
Pharma R&D dollars are spreading across biosimilars, combination therapies, and gene therapy, balancing near-term commercial returns with high-risk innovation.
Merck joins India’s crowded biomanufacturing push as global life-science suppliers expand local capacity, training infrastructure and customer support.
Pharma investment is accelerating across hospitals, biosimilars, manufacturing and healthcare infrastructure, revealing changing industry growth priorities.
Gilead just raised the bar in the long-acting HIV prevention race with expanded licensing for investigational once-yearly lenacapavir.
Dr. Reddy’s Laboratories enters India’s nivolumab race with Nivorz, adding biosimilar competition to the cancer drug market.
Lilly claims 30 percent share as the oral weight-loss race intensifies, challenging Novo Nordisk’s early lead in the growing obesity treatment market.
China’s Wegovy approval for MASH strengthens Novo Nordisk’s global position, extending the GLP-1 drug’s reach from weight management into liver disease.
In an interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Jayakumar A V, President (Quality), Ajanta Pharma Ltd, discusses how pharmaceutical manufacturers can turn deviation management from a compliance exercise into a strategic
BMS’s third CAR-T bet pays off as arlo-cel shows meaningful response gains in heavily pretreated multiple myeloma patients.
.jpg)
, CDSCO.jpg)